An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

NCT01328522 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

NCT00891046 ·Status: COMPLETED ·Phase: PHASE3

Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers

NCT00782600 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

NCT00414661 ·Status: COMPLETED

Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

NCT02094326 ·Status: COMPLETED

Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis

NCT01961310 ·Status: COMPLETED

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

NCT00929357 ·Status: COMPLETED

Faecal Analyses in Rheumatoid Arthritis Therapy

NCT03775824 ·Status: COMPLETED

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Microbial Dysbiosis in Rheumatoid Arthritis

NCT03802890 ·Status: UNKNOWN

An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

NCT02590562 ·Status: COMPLETED

Rheumatoid Arthritis Synovial Tissue Biopsy Study

NCT07000890 ·Status: COMPLETED ·Phase: NA

Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis

NCT02874092 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy

NCT00076206 ·Status: TERMINATED ·Phase: PHASE2

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

NCT04428502 ·Status: COMPLETED

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

NCT00252668 ·Status: COMPLETED ·Phase: PHASE4

Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients

NCT02476084 ·Status: COMPLETED

A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects

NCT01011959 ·Status: COMPLETED ·Phase: PHASE1

Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs

NCT03496831 ·Status: COMPLETED

Choosing Tests Wisely in Rheumatology

NCT03240536 ·Status: COMPLETED ·Phase: NA

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

NCT04428424 ·Status: COMPLETED

Circadian RA Study in Rheumatoid Arthritis Subjects

NCT03178955 ·Status: WITHDRAWN

Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)

NCT02662985 ·Status: COMPLETED ·Phase: PHASE3

Synovial Fluid Bank From Arthritic Patients

NCT00512343 ·Status: RECRUITING